What are you searching for?

05.05.2022 | Tracker

Top 50 Pharma Tracker

CREATION Team photo of Marketing Assistant Chawanzi Chintu By Francesca Gan and Chawanzi Chintu

Top 50 Pharma Tracker: HCPs track Pharma Covid-19 developments online

Discover what healthcare professionals (HCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are HCPs responding to drug launch news? How are HCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of HCPs across the globe discussing these topics and more.

The Top 50 Pharmaceutical Companies mentioned by HCPs on Twitter

April RankMarch RankCompany
Name
Total
Mentions
Account
Mentions
Account
Retweets
11Pfizer7,12873732
22Johnson & Johnson1,08044141
33AstraZeneca1,00640831
44GSK41811634
58Abbott39234934
611Gilead Sciences38319724
77Roche35817851
85Novartis3502474
918Lilly28221719
1010Biogen2671643
119Bayer24712114
1216BMS22519929
1312Sanofi21813037
1414Merck & Co21114729
156Novo Nordisk1821549
1617AbbVie1461276
1713Fresenius14511922
1820Amgen127915
1915Takeda11911054
2019Boehringer Ingelheim957117
2135Astellas95884
2229Otsuka77433
2321Regeneron51213
2425Teva42372
2527Merck KGaA413718
2622UCB37262
2726Eisai343123
2834Bausch3354
2933Chugai2913
3028CSL272722
3124Servier26152
3223Daiichi Sankyo2580
3332Allergan2252
3431Ipsen19111
3540Alexion13106
3638Grifols1200
3737Vertex880
3830Menarini610
3936Mylan600
4039Sun630
4142Mitsubishi Tanabe Pharma110
5050Jiangsu Hengrui000
5050Ono000
5050Endo000
5050Meiji000
5050Yunnan Baiyao000
5041Aurobindo000
5050Sino000
5050Shanghai000
5050Sumitomo Dainippon000

The latest insights from HCPs mentioning the Top 50 Pharmaceutical Companies

The five pharmaceutical companies that were mentioned the most by healthcare professionals (HCPs) on Twitter during April 2022 were Pfizer, Johnson & Johnson, AstraZeneca, GSK and Abbott.

 

CREATION.co identified a 31% decrease in mentions of pharmaceutical companies by HCPs this month compared to last month, decreasing to 13,006 posts from 18,993. Conversations continued to revolve around COVID-19 vaccine efficacy with HCPs sharing opinions and data about the efficacy of booster vaccines and mixing and matching. In particular HCPs discussed the effectiveness of the Pfizer vaccine against the Omicron variant after a third dose.

The top shared links by HCPs discussed efficacy of COVID-19 vaccines and the success of tirzepatide for treating obesity:

  1. A Nordic Cohort study about the SARS-CoV-2 vaccination and myocarditis carried out on 23 Million Residents.
  2. A news release about Lilly’s tirzepatide SURMOUNT-1 trial results.
  3. A Report from the FDA about the post marketing experience of Pfizer’s vaccine.

Chart showing HCPs discussing vaccine efficacy

Notably this month, HCPs celebrated the efficacy of Lilly’s tirzepatide for obesity patients and shared a report by Lilly that documented trial data from phase 3 of the SURMOUNT-1 study. The report stated that an average weight loss of 20.9% of body weight for patients on this highest dose of the drug was achieved.

CREATION.co continues to analyse online HCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.

To stay up to date, you can sign up to CREATION.co’s monthly eJournal.

Methodology notes:

  • In April 2022, CREATION Pinpoint® identified 13,006 healthcare professional (HCP) authored tweets from 5,363 individual HCPs mentioning a Top 50 Pharmaceutical company (according to revenue). 
  • Data for this research was analysed from the online Twitter conversations of HCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 April and 31 April 2022.
  • Unless otherwise specified, mentions of a company are not limited to its Twitter account(s).
  • In some cases, a tweet may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
  • Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen. In April 155 of these posts mentioned Janssen.

The Top 50 Pharma tracker archive

March 2022: HCPs compare immune responses of T cell, B cell, and Antibodies to different COVID-19 vaccines.

Top 50 Table
Top 50 Insights

February 2022: HCPs discuss Healthcare inequity and vaccination of under 5 year olds

Top 50 Table
Top 50 Insights

January 2022: HCPs get political when discussing Regeneron’s COVID-19 treatment

Top 50 Table
Top 50 Insights

December 2021: Omicron variant dominates HCP conversation in December 2021

Top 50 Table
Top 50 Insights

November 2021 : HCPs discuss trial data of Pfizer’s COVID-19 booster vaccine and oral treatment

Top 50 Table
Top 50 Insights

October 2021 : Pfizer most discussed company with booster and children’s COVID-19 jabs

Top 50 Table
Top 50 Insights

July 2021: HCPs discuss “booster shot” to decrease the high spread of the Delta variant

Top 50 Table
Top 50 Insights

June 2021: HCPs discuss effectiveness of COVID-19 vaccines against delta strain.

Top 50 Table
Top 50 Insights

May 2021: HCPs discuss accessibility of COVID-19 treatments globally.

Top 50 Table
Top 50 Insights

April 2021: HCPs reassure the public as they discuss COVID-19 vaccine side effects.

Top 50 Table
Top 50 Insights

March 2021: Oxford-AstraZeneca vaccine provokes HCP conversation as they discuss blood clots as a side effect.

Top 50 Table
Top 50 Insights

February 2021: J&J FDA approval of single-dose vaccine stirs HCP conversations

Top 50 Table
Top 50 Insights

January 2021: J&J new vaccine data drives increase in company posts online

Top 50 Table
Top 50 Insights

December 2020: COVID-19 makes up 84% of total conversation

Top 50 Table
Top 50 Insights

November 2020: Vaccine success dwarfs all other conversation.

Top 50 Table
Top 50 Insights

October 2020: Regeneron tops list due to high profile COVID-19 treatment conversation.

Top 50 Table
Top 50 Insights

September 2020: ASTRAZENECA’S VACCINE TRIAL SAFETY DISCUSSED BUT TRANSPARENCY IS CELEBRATED.

Top 50 Table
Top 50 Insights

August 2020: HCPS DISCUSS ASTRAZENECA MORE THAN GILEAD FOR FIRST TIME SINCE PANDEMIC

Top 50 Table
Top 50 Insights

July 2020: COVID-19 CANDIDATES TAKE OVER ALL HCP CONVERSATION

Top 50 Table
Top 50 Insights

June 2020: HCPs respond to COVID-19 treatment options

Top 50 Table
Top 50 Insights

May 2020: HCPs track pharma covid-19 developments online

Top 50 Table
Top 50 Insights

April 2020: HCPS RESPOND TO PHARMA COVID-19 ACTIVITY

Top 50 Table
Top 50 Insights

March 2020: HCPS MENTIONING PHARMA IN RELATION TO COVID-19

Top 50 Table
Top 50 Insights

February 2020: HCPS DISCUSS GILEAD, EISAI AND MERCK & CO’S TRIAL RESULTS

Top 50 Table
Top 50 Insights

January 2020: NEW YEAR BEGINS WITH FAILED TRIALS AND SUCCESSFUL PODCAST LAUNCH

Top 50 Table
Top 50 Insights

December 2019: @NOVARTIS MOST MENTIONED TWITTER ACCOUNT FOR SECOND MONTH

Top 50 Table
Top 50 Insights

November 2019: GILEAD INTO TOP 5 AFTER PRICE DISCREPANCY

Top 50 Table
Top 50 Insights

October 2019: HCPS ENGAGE WITH TOP 50 PHARMA AROUND GOOD AND BAD NEWS

Top 50 Table
Top 50 Insights

September 2019: HCPS ENGAGED MEANINGFULLY WITH TOP 50 PHARMA

Top 50 Table
Top 50 Insights

August 2019: #WHATHCPSTHINK ABOUT THE TOP 50 PHARMA

Top 50 Table
Top 50 Insights

View all articles >

Meet the Authors

Francesca Gan

Fran analyses the unprompted online conversations of healthcare professionals to produce actionable insights for clients. Her background in legal research provides a solid foundation in critical thinking and enables a well rounded approach to her data research.

Fran has a keen interest in netball and is a big follower of the New Zealand domestic netball league. She is also a lover of board games and card games, especially ones that involve shouting!

CREATION Team photo of Marketing Assistant Chawanzi Chintu

Chawanzi Chintu

As a Marketing assistant,Chawanzi has a passion for creativity and forward-thinking. With a background in media and communications these skills goes hand in hand when it comes to thinking of new and innovative ways to facilitate various marketing processes.

In her free time, Chawanzi balances her time taking care of her cat, pebbles and relaxing with a hydrating face mask.

Suggested next


01.10.2020 | Article

Top 50 Pharma Tracker: AstraZeneca’s vaccine trial safety discussed but transparency is celebrated.

Discover what healthcare professionals (HCPs) think about Top 50 pharmaceutical companies

By Mary Kangley

19.01.2017 | Whitepaper

White Paper: Professional Network: How HCPs are using social media professionally

Written by CEO Daniel Ghinn, originally printed in Innovations in Pharmaceutical Technology

By Daniel Ghinn

View all articles >